{
    "code": "02017057",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02017057",
    "time": "2020-06-19 03:13:16",
    "許可證字號": "衛署藥輸字第017057號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "113\/02\/14",
    "發證日期": "103\/02\/14",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00201705701",
    "中文品名": "普洛舒定ＶＲ小兒用５００微克／亳升",
    "英文品名": "PROSTIN VR PEDIATRIC 500 MICROGRAMS PER ML",
    "適應症": "用於先天性心臟缺損之新生兒緩解但非最終的治療，此療法可幾暫時維持動脈導管之開放至矯正手術施行為止，（先天性心臟缺損包括肺閉鎖，肺狹窄，三尖瓣閉鎖，法祿氏四疊症，主動脈弓中斷，主動脈狹窄或伴有無其它缺陷之大血管轉位",
    "劑型": "270注射劑",
    "包裝": "1毫升安瓿 100安瓿以下盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "ALPROSTADIL (PGE1)",
    "限制項目": "02輸　入",
    "申請商名稱": "1504401100  輝瑞大藥廠股份有限公司",
    "申請商地址": "台北市信義路松仁路100號42、43樓",
    "主製造廠": [
        {
            "製造廠名稱": "FUS0196100  PHARMACIA &amp; UPJOHN COMPANY LLC",
            "製造廠廠址": "7000 Portage Road, Kalamazoo, MI, 49001, USA",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": ""
        }
    ],
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "6832001600",
            "成分名稱": "ALPROSTADIL (PGE1)",
            "含量描述": "0.50",
            "含量": "0.5000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "普洛舒定VR外觀-108-08-26(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02017057&Seq=002&Type=10"
        },
        {
            "title": "Prostin VR Pediatric 500mcg per ml_20150917-104-09-17(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02017057&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "Prostin VR LLD USPI 201304-1-107-12-19.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02017057&Seq=003&Type=9"
        },
        {
            "title": "普洛舒定VR外盒-108-08-26(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02017057&Seq=004&Type=8"
        },
        {
            "title": "PROSTIN VR-標籤-107-12-19.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02017057&Seq=003&Type=8"
        },
        {
            "title": "PROSTIN VR-外盒-107-12-19.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02017057&Seq=002&Type=8"
        }
    ]
}